-

Owkin Announces Availability of K Pro in the AWS Marketplace SaaS Category

PARIS--(BUSINESS WIRE)--Owkin, a leading provider of agentic AI solutions for biopharma, today announced the availability of K Pro in the SaaS category of AWS Marketplace. Customers can now use AWS Marketplace to easily discover, buy, and deploy AI agents solutions, including Owkin’s agentic AI co-pilot for biopharma using their AWS accounts, accelerating agent and agentic workflow development.

"By offering K Pro in AWS Marketplace we're providing customers with a streamlined way to access our agentic AI co-pilot, helping them buy and deploy agent solutions faster and more efficiently." - Adi Ravia, Head of Product at Owkin.

Share

K Pro helps organizations make smarter decisions across their discovery and development pipeline by delivering decision-grade, data-driven biological insights, enabling customers to increase clinical success rates and change program trajectories.

"By offering K Pro in AWS Marketplace we're providing customers with a streamlined way to access our agentic AI co-pilot, helping them buy and deploy agent solutions faster and more efficiently." said Adi Ravia, Head of Product at Owkin. "Our customers in biotech, pharmaceuticals and research are already using these capabilities to access and analyse deep multimodal patient data, understand and review the scientific literature and uncover treatment-relevant biomarkers, demonstrating the real-world value of K Pro."

K Pro delivers essential capabilities including natural language interaction, biological reasoning, and proprietary multimodal data access. These features enable customers to unify fragmented workflows into an insight-driven research experience.

With the availability of SaaS in AWS Marketplace, customers can significantly accelerate their procurement process to drive AI innovation, reducing the time needed for vendor evaluations and complex negotiations. With centralized purchasing using AWS accounts, customers maintain visibility and control over licensing, payments, and access through AWS.

To learn more about K Pro in AWS Marketplace, visit https://aws.amazon.com/marketplace/pp/prodview-janhwocmshmxm.

About Owkin: Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biology Artificial Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software. At the heart of this system is K Pro, an AI copilot and its new LLM finetuned on biology called OwkinZero, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster.

Contacts

To request an interview with Owkin and AWS, please contact aws.france@wpp.com.

Owkin



Contacts

To request an interview with Owkin and AWS, please contact aws.france@wpp.com.

Social Media Profiles
More News From Owkin

Université Paris-Saclay and Owkin: A Unique Alliance to Propel University Medical Research to the Top of the European Rankings Through AI

PARIS--(BUSINESS WIRE)--Université Paris-Saclay and Owkin announce the signing of a memorandum of understanding to explore the potential of K Pro Free - Owkin’s AI co-pilot for biology - for use by Paris-Saclay. K Pro Free will now be available to the entire Université Paris-Saclay community, and in particular teachers, researchers and doctoral students working in the biomedical sciences. The partnership includes workshops, training sessions and events designed to promote the discovery and adop...

Owkin Unveils Europe’s First Pan-European Agentic Infrastructure for Biology at the Franco-German Digital Sovereignty Summit

BERLIN--(BUSINESS WIRE)--At today’s Franco-German Summit on Digital Sovereignty in Berlin, Owkin, together with leading academic partners Gustave Roussy (France) and Charité Comprehensive Cancer Center (Germany), announced a landmark initiative to build the first pan-European agentic infrastructure to make biological data AI-ready, as a key step towards biological super intelligence. The project aims to develop and deploy modern AI methods to support biological research and drug development. An...

Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x

NEW YORK & PARIS--(BUSINESS WIRE)--Owkin launches K Navigator, a ground-breaking agentic AI co-pilot to speed up breakthroughs in biomedical research by 20x...
Back to Newsroom